Joy is an analyst in the New Businesses fund. Previously, he worked as a consultant for Deloitte UK where he served large Life Science clients in projects spanning strategy, operations and technology transformation. Joy has industry experience as a process engineer at Eli Lilly’s biotechnology launch facility and various research and commercial internships in the sector. Joy has a BEng in Biochemical Engineering from University College London (UCL) and an MPhil in Bioscience Enterprise from the University of Cambridge. His practical research has revolved around innovative bioprocessing and synthetic biology, with a focus on cost-effectiveness for applications such as bioremediation. For is master’s thesis, he developed health economic and financial models to inform biomarker investment decisions at Merck KGaA’s Innovation Center in Germany. Joy is based in Amsterdam.